Supplementation with cholecalciferol during pregnancy linked to increased bone mineral content, bone mineral density, lean mass in offspring ...

The Company is seeking approval of tirzepatide for the treatment of HFpEF and obesity and has submitted data to the FDA. Detailed results were announced from a phase 3 clinical trial evaluating the ...

The resubmitted sBLA will include results from Study C, which evaluated biologic-naive patients with uncontrolled CSU on antihistamines.

Danziten is a twice daily, oral medication that inhibits the BCR-ABL tyrosine kinase. Nilotinib was originally approved under the brand name Tasigna; it is currently indicated for adults and pediatric ...

Catriona Reddin, MB, BCh, from the University of Galway in Ireland, and colleagues examined whether the importance of individual risk factors for stroke differ by stroke severity. Stroke severity was ...

Dementia death rates stable between 2018 and 2019, then increased in 2020, and declined in 2022, with the rate higher than 2018, 2019 ...

The Food and Drug Administration (FDA) has granted accelerated approval to Kebilidi™ (eladocagene exuparvovec-tneq) for the treatment of adult and pediatric patients with aromatic L-amino acid ...

The Food and Drug Administration (FDA) has expanded the approval of Nerivio ® (Theranica) to include the acute and/or ...

The detailed results were published in The New England Journal of Medicine and were presented at ObesityWeek 2024.

Source: Getty Images “The potential adverse impact of chemotherapy exposure during pregnancy is likely mediated through ...